🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 254604101 (prev. 36870G105 )
- Market Cap
- Mid Cap
- IPO
- 8/14/2020 · $10.00/share
- Previous Symbol
- GMTX (changed 12/29/2022)
- Previous Name
- Gemini Therapeutics, Inc.
Business: Disc Medicine, Inc is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases.
Notes: February 5, 2021-- Gemini Therapeutics, Inc. (f/k/a FS Development Corp.), a Delaware corporation (the “Company”), completed the transactions contemplated by the Merger Agreement, dated as of October 15, 2020, among the Company, FSG Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), Gemini Therapeutics Sub, Inc., a Delaware corporation (“Old Gemini”), and Shareholder Representative Services LLC, pursuant to which Merger Sub merged with and into Old Gemini, with Old Gemini surviving the merger as a wholly-owned subsidiary of the Company.
Company Contact
- CEO
- John Quisel
- CFO
- Joanne Bryce
- Headquarters
- 321 Arsenal Street, Suite 101, Watertown, MA 02472
- Phone
- 617-674-9274
- Investor Relations
- Christina Tartaglia, Stern IR · christina.tartaglia@sternir.com